Adaptive Biotechnologies Corporation (1HM BE) stock market data APIs
€14.3097
0.45(3.1%)
as of October 17, 2025
Try our APIs with
free plan!
Adaptive Biotechnologies Corporation Financial Data Overview
Price chart is built with
Anychart
Prev. Close
14.3097
Open
14.7639
High
14.849
Low
13.9665
52 wk Range
4.101-15.105
Market Cap
3 337 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corporation data using free add-ons & libraries
Get Adaptive Biotechnologies Corporation Fundamental Data
Adaptive Biotechnologies Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Adaptive Biotechnologies Corporation End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corporation News
New
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
Adaptive Biotechnologies SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook
In the past week, Adaptive Biotechnologies received an improved earnings outlook from analysts, with the consensus full-year earnings estimate rising by 17.6% in the most recent quarter and the compan...
Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum
Adaptive Biotechnologies (ADPT) may not have made headlines with a big announcement this week, but the recent movement in its share price has plenty of investors pausing. When a stock like this ticks ...
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adaptive Biotechnologies (ADPT) been one of those stocks this...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
